August 4, 2008 - Bioheart Inc. said last week it entered into a letter of intent to acquire MEDICALGORITHMICS Ltd. and the worldwide rights to the POCKETECG, a real-time wireless beat-to-beat, intelligent heart monitor and diagnostic system, designed for long-term, fully-automated electrocardiogram (ECG) arrhythmia analysis.

The device, manufactured by MEDICALGORITHMICS in Poland recently received CE mark approval for marketing throughout Europe.

August 4, 2008 - 
Levitronix and FDA are notifying healthcare professionals of a class 1 recall of the Levitronix CentriMag Extracorporeal Blood Pumping System and Primary and Backup Consoles manufactured by Levitronix, GmbH, Zurich, Switzerland.

August 4, 2008 - EKR Therapeutics Inc., said today it received FDA approval for Cardene I.V. (nicardipine hydrochloride) premixed injection, a patented, ready-to-use, single use intravenous bag for the administration of this calcium channel blocker.

The 200 ml RTU bags contain 20 mg of the anti-hypertensive agent nicardipine hydrochloride (0.1 mg/ml) in either dextrose or sodium chloride.

August 4, 2008 - The Institute for Safe Medication Practices (ISMP) recently warned about the dangers of accidentally giving topical thrombin intravascularly, since some packages come with a syringe.

August 1, 2008 – The Centers for Medicare & Medicaid Services (CMS) yesterday issued a final ruling for three new hospital errors or conditions it will no longer pay for, including: surgical site infections following certain elective procedures, including certain orthopedic surgeries, and bariatric surgery for obesity; certain manifestations of poor control of blood sugar levels; and deep vein thrombosis or pulmonary embolism following total knee replacement and hip replacement procedures.

August 1, 2008 - Osmetech said this week at the American Association for Clinical Chemistry (AACC) 2008 Conference and Exhibition in Washington, D.C., that following receipt of its 510(k) clearance last week from the FDA the company has commenced shipments of its second generation eSensor XT-8 molecular diagnostics platform and Warfarin Sensitivity Test.

August 1, 2008 - Healthcare professionals need an authoritative resource on the Internet designed to quickly provide answers to urgent treatment questions, so Epocrates partnered with BMJ Group, publisher of the British Medical Journal, to create a new online product that delivers practical and up-to-date disease diagnosis and treatment guidelines.

The RADPAD #2214-06 Femoral-Entry Angiography Shield for coronary, RADPAD #2215-04A Peripheral Drape for peripheral procedures and the RADPAD #2217-01A EP Left Subclavian Shield for device implantation procedures are designed to reduce the radiation exposure of interventional cardiologists and electrophysiologists, reducing exposure by up to 95 percent, according to Worldwide Innovations & Technologies.

July 31, 2008 — eHealth Global Technologies released its eHealthConnect online request service designed to streamline the process required for institutions to retrieve outside patient medical records for referred-in patients.

The online request service provides customized forms for each healthcare institution customer of eHealth Global, and automatically generates the appropriate HIPAA release of information forms to allow access to these records under HIPAA guidelines.

July 31, 2008 – No major difference was found in long-term safety or efficacy between sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES), according to a recent study that found both stent types were efficacious in reducing revascularization, but were limited by a small continual increase in late stent thrombosis.

The study appears in the Aug. 1 issue of the American Journal of Cardiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now